Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing surveillance for Hunterase ICV injection 15 mg
jRCT2031220251Recruiting
- Sponsor
- Clinigen
- Start
- May 2021
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of Idursulfase beta in mucopolysaccharidosis type 2, sponsored by Clinigen. Primary endpoints: Patient background characteristics, Incidence of anaphylaxis and 9 more. Started May 2021; status: recruiting.
02
Drugs
Idursulfase beta
03
Conditions
mucopolysaccharidosis type 2
Beyond the preview
Go deeper on jRCT2031220251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031220251.